CVS Health Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 292.11B | 322.47B | 357.78B | 372.81B | 402.07B | 7.8% | |
| Cost of Revenue | (239.99B) | (267.96B) | (303.35B) | (321.41B) | (346.70B) | 7.9% | |
Gross Profit | 52.12B | 54.50B | 54.43B | 51.40B | 55.36B | 7.7% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | — | — | — | (41.23B) | — | -100.0% | |
| Depreciation & Amortization | (4.49B) | (4.22B) | (4.37B) | (4.60B) | (4.61B) | 0.2% | |
Operating Income (EBIT) | 13.31B | 7.95B | 13.74B | 8.52B | 10.38B | 21.9% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (2.50B) | (2.29B) | (2.66B) | (2.96B) | (3.12B) | 5.4% | |
| Other Income/Expenses (Net) | -2.77B | -2.12B | -2.57B | -2.37B | -8.25B | 248.4% | |
Income Before Tax | 10.54B | 5.84B | 11.17B | 6.15B | 2.14B | -65.3% | |
| Income Tax Expense | (2.55B) | (1.51B) | (2.81B) | (1.56B) | (408.00M) | -73.9% | |
Net Income | 8.00B | 4.31B | 8.34B | 4.61B | 1.77B | -61.7% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $6 | $3 | $6 | $4 | $1 | -61.7% | |
| Weighted Avg Shares Outstanding | 1.32B | 1.31B | 1.28B | 1.26B | 1.27B | 0.6% | |
| Weighted Avg Shares Outstanding (Diluted) | 1.33B | 1.32B | 1.29B | 1.26B | 1.27B | 0.7% | |
EBITDA | 17.53B | 12.35B | 18.20B | 13.68B | 9.86B | -27.9% |
Explore CVS
CVS in the Healthcare
Large Cap